Market probably thinks:
So the sensible conclusion is to wait and see what happens.
- growth in dollar terms is small
- costs are high
- it's already valued over $100m
- medical trials usually fail
Ann: Q4 FY23 Quarterly Investor Presentation, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.13M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 17.0¢ | $16.45K | 96.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 60000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 18052 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MAP (ASX) Chart |